Home >> Business >> Anti-Inflammatory Therapeutics Market To Reach Worth US$ 130.6 Bn By 2026 – Credence Research

Anti-Inflammatory Therapeutics Market To Reach Worth US$ 130.6 Bn By 2026 – Credence Research

According to the latest report published by Credence Research, Inc. “Anti-inflammatory Therapeutics Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global anti-inflammatory therapeutics market is projected to reach US$ 130.6 Bn by 2026, expanding at a CAGR of 8.5% from 2018 to 2026.

Market Insights                                                  

Anti-inflammatory therapeutics market projected to US$ 130.6 Bn by 2026 with CAGR of 8.5% throughout the forecast period from 2018 to 2026. Biologics and immune selective anti-inflammatory derivatives (ImSAIDs) are the promising drugs classes that will play the main role in the market. Global anti-inflammatory therapeutics market from 2018-2026 study is based on exhaustive analysis with insights from industry stakeholders. The detailed study incorporates the market landscape and its growth scenarios for the forecasting period from 2018-2026.

According to World Health Organization (WHO), around 235 Mn individuals experience the ill effects of asthma around the globe. Symptomatic help amid the inflammation gives alleviation to the patients suffering from inflammatory diseases. In spite of the fact that there are numerous anti-inflammatory drugs present in the market, still, there is an essential requirement for better and novel anti-inflammatory therapeutics drugs with slighter side effects and improved efficacy.

Anti-Inflammatory Therapeutics Market

Based on the drug types, the global anti-inflammatory therapeutics market is segmented into biologics, corticosteroids, immune selective anti-inflammatory derivatives (ImSAIDs), and non-steroidal anti-inflammatory drugs (NSAIDs); additionally, the indication studied in this report are categorized into COPD, multiple sclerosis, IBD, psoriatic arthritis, gout, and Others (Osteoarthritis, Systemic Lupus, Psoriasis). Rising prevalence of inflammatory diseases and the strong drug pipeline would additionally boost the anti-inflammatory therapeutics market.

Browse the full report Anti-inflammatory Therapeutics Market – Growth, Future Prospects and Competitive Analysis, 2018–2026 report at http://www.credenceresearch.com/report/anti-inflammatory-therapeutics-market

Geographically, overall anti-inflammatory therapeutics market is projected for Europe, Middle East and Africa, Asia Pacific, Latin America, and North America. As for the revenue share, in 2017, North America drives the global market and projected that the situation will remain steady amid the forecast period. However, the dominance of North America will be evidently challenged by the Asia Pacific. There are huge chances for market penetration in countries like Mexico, India, and China to the market occupiers at present having a hold in established countries. The need for anti-inflammatory therapeutics drugs has become prominent in the Asia Pacific due to rapid development of the economy, developing healthcare facilities and immense patient base.

Related Reports:

Surgical Sutures Market

Diabetes Drugs Market

Spinal Implants and Surgical Devices Market

Leave a Reply

Your email address will not be published. Required fields are marked *